NRC HEALTHNRC
ASignal's systematic analysis rates NRC as Bearish.
Reflects the latest available analysis · analyzed Oct 2, 2026
The case on NRC
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Positive price momentum (0.045)
- RSI near neutral zone (52.22), not overbought
- Gross margin above 50% (61.75%) indicating pricing power
- Positive free cash flow ($20.28M)
- High return on equity (42.03%) suggesting strong capital efficiency
- Negative MACD histogram indicating weakening bullish momentum
- Operating margin negative (-0.22%)
- High debt-to-equity ratio (13.81x) raising financial risk concerns
- Low current and quick ratios (0.65x, 0.49x) indicating liquidity pressure
- Extremely high dividend yield (302%) with payout ratio (250%) unsustainable
- Only two news sources with no Reddit mentions, indicating low market sentiment coverage
See the full verdict on NRC
ASignal Rank (1-4), confidence score, Buffett / Ackman / Dalio grades, price targets, and the full reasoning behind the call.
How ASignal analyzes NRC
Most investors never get a second opinion, let alone several. ASignal runs NRC past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: Warren Buffett's value discipline, Bill Ackman's activist lens, and Ray Dalio's macro view. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.